A carregar...
Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide
Screening for rare diseases first began more than 50 years ago with neonatal bloodspot screening (NBS) for phenylketonuria, and carrier screening for Tay-Sachs disease, sickle cell anaemia and β-thalassaemia. NBS’s primary aim is health gain for children, while carrier screening enables autonomous r...
Na minha lista:
| Publicado no: | J Community Genet |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141077/ https://ncbi.nlm.nih.gov/pubmed/33074550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12687-020-00488-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|